|
Market Cap (17-May) $18,062,432 (1,390th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 0 |
Shortsold (21-Feb) 50,867 (0.01%) (619th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.06 |
AC8 released this announcement to the ASX on 21 September 2021, 9:15. The announcement is not marked as price sensitive, and is 1 page(s) in length and 122.38kb in size.
You can view all announcements from AC8 and see how they appear on a price chart on the announcements page.
At the date of this announcement, AC8 was 0.080% short sold according to ASIC data. It was ranked the 470th most shorted stock on the ASX. It remains ranked 619th as of the latest reported data (21 February 2022).
| Other Recent Announcements from AC8 | |
|---|---|
| Final Director's Interest Notice - C. Mews | 29 June 2023, 9:44 |
| Initial Director's Interest Notice - B. Mitchell | 29 June 2023, 9:44 |
| Appointment of Independent Non-Executive Director | 29 June 2023, 9:19 |
| AusCann to Accelerate Human Drug Development Program | 21 September 2021, 9:15 |
| AusCann Appoints US Advisors to Advance CPAT-01 FDA Program | 9 September 2021, 8:20 |
| Key Company Highlights & Financial Commentary for FY2021 | 30 August 2021, 9:23 |
| Appendix 4E and Annual Financial Statements | 30 August 2021, 9:21 |
You must be logged in to post a reply.
AusCann Group Holdings Ltd 